Biovista announces that its President, Dr. Aris Persidis, will participate in the “VA BIOTECH – Concept to Commercialization” Facebook event. About VA BIOTECH – Concept to Commercialization event: Charlottesville is home to some of the most cutting edge biotechnology firms in the Country. This panel, presented in partnership with U.Va. Innovation and Charlottesville Business Innovation … Read More
Events
Biovista – NIH/DAIDS Seminar on use of MoA to predict Safety Signals
Biovista announces that its President, Dr. Aris Persidis, will give a seminar at the NIH/DAIDS Medical Officer’s Safety Forum on Thursday, March 28th. The seminar, is entitled “Using Mechanism of Action to Predict Safety Signals and Understanding Sub-Populations.” With the web being increasingly used to determine side effects of drugs, and with self-reporting patient social networking databases … Read More
Partnering for Cures – Biovista presentation
Presentation- CFIDS Association of America / Biovista View the joint presentation by Biovista President Dr. Aris Persidis and CFIDS’ Scientific Director, Dr. Suzanne Vernon at the 2012 Partnering for Cures conference. The collaboration between the CFIDS Association of America and Biovista leverages the accumulated knowledgebase for chronic fatigue syndrome (CFS) and Biovista’s state-of-the-art approaches to … Read More
World Drug Repositioning Congress
Join us at the upcoming World Drug Repositioning Congress, 4 – 5 December 2012, 20 F Street NW Conference Center, Washington, DC, US Biovista’s Aris Persidis is presenting a talk titled Very large scale systematic drug repositioning as a business and technology driver Topics covered include: Big data technologies enabling the deployment of systemic drug … Read More
Partnering for Cures meeting
Join us at the upcoming Partnering for Cures meeting, November 28-30, 2012 in NY City. Biovista will be co-presenting with the CFIDS Association of America its repositioning work on Chronic Fatigue Syndrome within the event’s prestigious Innovator Presentations session. The session focuses on organizations “engaged in innovative, cross-sector collaborations aimed at reducing the time … Read More